12/11
04:47 pm
ser
Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of Chemistry [Yahoo! Finance]
Low
Report
Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of Chemistry [Yahoo! Finance]
12/11
04:15 pm
ser
Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of Chemistry
Low
Report
Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of Chemistry
12/10
04:30 pm
ser
Serina Therapeutics Submits Complete Response to FDA Clinical Hold Letter for SER-252 Program
Medium
Report
Serina Therapeutics Submits Complete Response to FDA Clinical Hold Letter for SER-252 Program
11/13
06:10 am
ser
Serina Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights
Low
Report
Serina Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights
11/3
06:05 am
ser
Serina Therapeutics Provides Regulatory Update on SER-252 Program
Medium
Report
Serina Therapeutics Provides Regulatory Update on SER-252 Program
10/8
11:00 am
ser
Serina Therapeutics Launches Enhanced Corporate Communications Platform to Strengthen Engagement with Patients, Clinicians, and Investors
Low
Report
Serina Therapeutics Launches Enhanced Corporate Communications Platform to Strengthen Engagement with Patients, Clinicians, and Investors
10/6
04:47 pm
ser
Serina Therapeutics Draws First $5 Million Funding Tranche to Support Registrational Trial of SER-252 in Parkinson's Disease [Yahoo! Finance]
Low
Report
Serina Therapeutics Draws First $5 Million Funding Tranche to Support Registrational Trial of SER-252 in Parkinson's Disease [Yahoo! Finance]
10/6
04:15 pm
ser
Serina Therapeutics Draws First $5 Million Funding Tranche to Support Registrational Trial of SER-252 in Parkinson’s Disease
Low
Report
Serina Therapeutics Draws First $5 Million Funding Tranche to Support Registrational Trial of SER-252 in Parkinson’s Disease